Minocycline: therapeutic potential in psychiatry (Q22241418)

6 February 2023

1

Olivia M.

Dean

Olivia M. Dean

1 reference

6 February 2023

João Data-Franco

2

João

Data-Franco

1 reference

1011511445

6 February 2023

Francesco Giorlando

series ordinal

3

author given names

Francesco

author last names

Giorlando

1 reference

1011511445

https://scigraph.springernature.com/pub.10.2165/11632000-000000000-00000

6 February 2023

language of work or name

English

0 references

publication date

May 2012

0 references

published in

CNS Drugs

0 references

volume

26

0 references

page(s)

391-401

0 references

issue

5

0 references

exact match

0 references

cites work

Minocycline and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Does minocycline have antidepressant effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Oxidative stress and neurodegeneration: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Lower serum vitamin E concentrations in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Oxidative stress in schizophrenia: an integrated approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Oxidative pathways as a drug target for the treatment of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders: is it specific to bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Nitric oxide modulation in protective role of antidepressants against chronic fatigue syndrome in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

The role of glutamate on the action of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

The neurochemical circuitry of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Glutamate transmission in addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Platelet glutamate receptor supersensitivity in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

A meta-analysis of cytokines in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Serological observations in patients suffering from acute manic episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Serum and plasma BDNF levels in major depression: a replication study and meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Inflammation is detrimental for neurogenesis in adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Possible antipsychotic effects of minocycline in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline as adjunctive therapy for schizophrenia: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline reduces prostaglandin E synthase expression and 8-isoprostane formation in LPS-activated primary rat microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Increased apoptosis and different regulation of pro-apoptosis protein bax and anti-apoptosis protein bcl-2 in the olfactory bulb of a rat model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Neuroprotective mechanisms of minocycline against sphingomyelinase/ceramide toxicity: Roles of Bcl-2 and thioredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Differential regulation of immediate-early gene expression in the prefrontal cortex of rats with a high vs low behavioral response to methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Hydrogen peroxide attenuates insulin-like growth factor-1 neuroprotective effect, prevented by minocycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline as a neuroprotective agent

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

The platelet as a peripheral marker in psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline prevents impaired glial glutamate uptake in the spinal sensory synapses of neuropathic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline affects cocaine sensitization in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Functional neuroimaging of minocycline's effect in a patient with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

A case of methamphetamine use disorder treated with the antibiotic drug minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Placebo-controlled trial of cytisine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Antidepressant drugs and cytokines in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Altered expression of neurotrophic factors in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Antipsychotic medication and oxidative cell stress: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Anti-inflammatory drugs in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Minocycline completely reverses mechanical hyperalgesia in diabetic rats through microglia-induced changes in the expression of the potassium chloride co-transporter 2 (KCC2) at the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

The specificity of platelet glutamate receptor supersensitivity in psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11632000-000000000-00000

Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia

21 January 2018

1 reference

12 December 2020

Possible antidepressant effect of minocycline

1 reference

12 December 2020

Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression

1 reference

12 December 2020

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

1 reference

12 December 2020

Minocycline for acne vulgaris: efficacy and safety

1 reference

12 December 2020

The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats.

1 reference

12 December 2020

Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression

1 reference

12 December 2020

Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms

1 reference

12 December 2020

Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms

1 reference

12 December 2020

Complementary medicine, self-help, and lifestyle interventions for obsessive compulsive disorder (OCD) and the OCD spectrum: a systematic review

1 reference

12 December 2020

Safety of long-term high-dose minocycline in the treatment of acne

1 reference

12 December 2020

Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia

1 reference

12 December 2020

10.2165/11632000-000000000-00000

Identifiers

DOI

0 references